FirmaIQ
Org.nr 991 036 393 2015 → 2016 Year-over-year analysis

PCI BIOTECH HOLDING ASA: årsregnskap 2016 vs 2015

Returned to profit, cash halved-plus

approved 2017-05-29; registry 2017-07-26; journal 2017 768527

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2016 with 2015 for PCI BIOTECH HOLDING ASA. Net result -152.71m NOK → +146.52m NOK. Equity 76.06m NOK → 223.57m NOK.

On the constructive side: turned profitable; equity strengthened. Pressures included: cash fell.

Also worth watching: sharp cash drawdown; book investments changed. All figures are taken from the published annual accounts for PCI BIOTECH HOLDING ASA.

At a glance

Scorecard

Revenue
n/m 0 NOK
—
Net result
-152.71m NOK +146.52m NOK
+196.0%
Equity
76.06m NOK 223.57m NOK
+193.9%
Cash
49.25m NOK 14.00m NOK
-71.6%
Total assets
76.89m NOK 224.63m NOK
+192.1%

What improved

  • ↑

    Turned profitable

    Net result flipped from a loss of 152.71m NOK to a profit of 146.52m NOK. Calculated

  • ↑

    Equity strengthened

    Book equity 76.06m NOK → 223.57m NOK (equity ratio 98.9% → 99.5%). Calculated

What deteriorated

  • ↓

    Cash fell

    Bank deposits 49.25m NOK → 14.00m NOK (-71.6% YoY). Calculated

Things to notice

  • ·

    Sharp cash drawdown

    Cash fell by more than 60% YoY (49.25m NOK → 14.00m NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation

  • ·

    Book investments changed

    Investment / intangible book value 59.60m NOK → 223.50m NOK. Reported fact